Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Isolation of galectin-1 from human platelets: its interaction with actin.

González MM, Yoshizaki L, Wolfenstein-Todel C, Fink NE.

Protein J. 2012 Jan;31(1):8-14. doi: 10.1007/s10930-011-9367-4.

PMID:
22081313
2.

Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis.

Sozio SM, Coresh J, Jaar BG, Fink NE, Plantinga LC, Armstrong PA, Longenecker JC, Sharrett AR, Powe NR, Parekh RS.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1292-300. doi: 10.2215/CJN.08350910. Epub 2011 May 5.

3.

Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J.

Am J Kidney Dis. 2010 Aug;56(2):348-58. doi: 10.1053/j.ajkd.2010.03.020. Epub 2010 Jun 3.

4.

Association of social support with outcomes in incident dialysis patients.

Plantinga LC, Fink NE, Harrington-Levey R, Finkelstein FO, Hebah N, Powe NR, Jaar BG.

Clin J Am Soc Nephrol. 2010 Aug;5(8):1480-8. doi: 10.2215/CJN.01240210. Epub 2010 Apr 29.

5.

Spoken language development in children following cochlear implantation.

Niparko JK, Tobey EA, Thal DJ, Eisenberg LS, Wang NY, Quittner AL, Fink NE; CDaCI Investigative Team.

JAMA. 2010 Apr 21;303(15):1498-506. doi: 10.1001/jama.2010.451.

6.

Inpatient hemodialysis initiation: reasons, risk factors and outcomes.

Crews DC, Jaar BG, Plantinga LC, Kassem HS, Fink NE, Powe NR.

Nephron Clin Pract. 2010;114(1):c19-28. doi: 10.1159/000245066. Epub 2009 Oct 9.

7.

Correlates and outcomes of fatigue among incident dialysis patients.

Jhamb M, Argyropoulos C, Steel JL, Plantinga L, Wu AW, Fink NE, Powe NR, Meyer KB, Unruh ML; Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Clin J Am Soc Nephrol. 2009 Nov;4(11):1779-86. doi: 10.2215/CJN.00190109. Epub 2009 Oct 1.

8.

Peripheral vascular disease-related procedures in dialysis patients: predictors and prognosis.

Plantinga LC, Fink NE, Coresh J, Sozio SM, Parekh RS, Melamed ML, Powe NR, Jaar BG.

Clin J Am Soc Nephrol. 2009 Oct;4(10):1637-45. doi: 10.2215/CJN.02220409. Epub 2009 Aug 13.

9.

Association of peritoneal dialysis clinic size with clinical outcomes.

Plantinga LC, Fink NE, Finkelstein FO, Powe NR, Jaar BG.

Perit Dial Int. 2009 May-Jun;29(3):285-91.

10.

Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study.

Sozio SM, Armstrong PA, Coresh J, Jaar BG, Fink NE, Plantinga LC, Powe NR, Parekh RS.

Am J Kidney Dis. 2009 Sep;54(3):468-77. doi: 10.1053/j.ajkd.2009.01.261. Epub 2009 Apr 19.

11.

Predicting behavior problems in deaf and hearing children: the influences of language, attention, and parent-child communication.

Barker DH, Quittner AL, Fink NE, Eisenberg LS, Tobey EA, Niparko JK; CDaCI Investigative Team.

Dev Psychopathol. 2009 Spring;21(2):373-92. doi: 10.1017/S0954579409000212.

12.

Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study.

Jaar BG, Plantinga LC, Crews DC, Fink NE, Hebah N, Coresh J, Kliger AS, Powe NR.

BMC Nephrol. 2009 Feb 6;10:3. doi: 10.1186/1471-2369-10-3.

13.

Transition from congress abstract to full paper: the case of a national Argentinean congress in clinical laboratory.

Martínez AM, Fink NE.

Clin Chem Lab Med. 2008;46(11):1568-74. doi: 10.1515/CCLM.2008.328.

PMID:
19012520
14.

MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

Kao WH, Klag MJ, Meoni LA, Reich D, Berthier-Schaad Y, Li M, Coresh J, Patterson N, Tandon A, Powe NR, Fink NE, Sadler JH, Weir MR, Abboud HE, Adler SG, Divers J, Iyengar SK, Freedman BI, Kimmel PL, Knowler WC, Kohn OF, Kramp K, Leehey DJ, Nicholas SB, Pahl MV, Schelling JR, Sedor JR, Thornley-Brown D, Winkler CA, Smith MW, Parekh RS; Family Investigation of Nephropathy and Diabetes Research Group.

Nat Genet. 2008 Oct;40(10):1185-92. doi: 10.1038/ng.232. Epub 2008 Sep 14.

15.

The association of sudden cardiac death with inflammation and other traditional risk factors.

Parekh RS, Plantinga LC, Kao WH, Meoni LA, Jaar BG, Fink NE, Powe NR, Coresh J, Klag MJ.

Kidney Int. 2008 Nov;74(10):1335-42. doi: 10.1038/ki.2008.449. Epub 2008 Sep 3.

16.

Heparin-induced antibodies and cardiovascular risk in patients on dialysis.

Asmis LM, Segal JB, Plantinga LC, Fink NE, Kerman JS, Kickler TS, Coresh J, Gardner LB.

Thromb Haemost. 2008 Sep;100(3):498-504.

17.

Lipoprotein(a) level as a predictor of cardiovascular disease and small apoliprotein(a) isoforms in dialysis patients: assay-related differences are important.

Longenecker JC, Coresh J, Klag MJ, Powe NR, Fink NE, Marcovina SM.

Clin Chim Acta. 2008 Nov;397(1-2):36-41. doi: 10.1016/j.cca.2008.07.012. Epub 2008 Jul 18.

18.

Accuracy of patients' reports of comorbid disease and their association with mortality in ESRD.

Cavanaugh KL, Merkin SS, Plantinga LC, Fink NE, Sadler JH, Powe NR.

Am J Kidney Dis. 2008 Jul;52(1):118-27. doi: 10.1053/j.ajkd.2008.02.001. Epub 2008 Apr 2.

19.

Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study.

Huang CX, Plantinga LC, Fink NE, Melamed ML, Coresh J, Powe NR.

Adv Chronic Kidney Dis. 2008 Jul;15(3):321-31. doi: 10.1053/j.ackd.2008.04.012.

20.

Serum phosphate levels and risk of infection in incident dialysis patients.

Plantinga LC, Fink NE, Melamed ML, Briggs WA, Powe NR, Jaar BG.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1398-406. doi: 10.2215/CJN.00420108. Epub 2008 Jun 18.

21.

Surgical factors in pediatric cochlear implantation and their early effects on electrode activation and functional outcomes.

Francis HW, Buchman CA, Visaya JM, Wang NY, Zwolan TA, Fink NE, Niparko JK; CDaCI Investigative Team.

Otol Neurotol. 2008 Jun;29(4):502-8. doi: 10.1097/MAO.0b013e318170b60b.

22.

Assessing the use of speech and language measures in relation to parental perceptions of development after early cochlear implantation.

Lin FR, Wang NY, Fink NE, Quittner AL, Eisenberg LS, Tobey EA, Niparko JK; CDaCI Investigative Team.

Otol Neurotol. 2008 Feb;29(2):208-13.

23.

Tracking development of speech recognition: longitudinal data from hierarchical assessments in the Childhood Development after Cochlear Implantation Study.

Wang NY, Eisenberg LS, Johnson KC, Fink NE, Tobey EA, Quittner AL, Niparko JK; CDaCI Investigative Team.

Otol Neurotol. 2008 Feb;29(2):240-5. doi: 10.1097/MAO.0b013e3181627a37.

24.

Electric charge requirements of pediatric cochlear implant recipients enrolled in the Childhood Development After Cochlear Implantation study.

Zwolan TA, O'Sullivan MB, Fink NE, Niparko JK; CDACI Investigative Team.

Otol Neurotol. 2008 Feb;29(2):143-8. doi: 10.1097/MAO.0b013e318161aac7.

PMID:
18223443
25.

Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.

Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR.

Nephrol Dial Transplant. 2008 May;23(5):1650-8. Epub 2007 Dec 8.

PMID:
18065788
26.

Sleep quality and its correlates in the first year of dialysis.

Unruh ML, Buysse DJ, Dew MA, Evans IV, Wu AW, Fink NE, Powe NR, Meyer KB; Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Clin J Am Soc Nephrol. 2006 Jul;1(4):802-10. Epub 2006 Jun 8.

27.

Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality.

Boulware LE, Liu Y, Fink NE, Coresh J, Ford DE, Klag MJ, Powe NR.

Clin J Am Soc Nephrol. 2006 May;1(3):496-504. Epub 2006 Mar 1.

28.

Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident-dialysis patients.

Jaar BG, Plantinga LC, Astor BC, Fink NE, Longenecker C, Tracy RP, Marcovina SM, Powe NR, Coresh J.

Adv Chronic Kidney Dis. 2007 Jul;14(3):304-13.

PMID:
17603986
29.

Childhood Development after Cochlear Implantation (CDaCI) study: design and baseline characteristics.

Fink NE, Wang NY, Visaya J, Niparko JK, Quittner A, Eisenberg LS, Tobey EA; CDACI Investigative Team.

Cochlear Implants Int. 2007 Jun;8(2):92-116.

30.

Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Plantinga LC, Fink NE, Levin NW, Jaar BG, Coresh J, Levey AS, Klag MJ, Powe NR.

Am J Kidney Dis. 2007 Jun;49(6):831-40.

PMID:
17533026
31.

Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients.

Merkin SS, Cavanaugh K, Longenecker JC, Fink NE, Levey AS, Powe NR.

J Clin Epidemiol. 2007 Jun;60(6):634-42. Epub 2006 Dec 11.

32.

Statin use and sepsis events [corrected] in patients with chronic kidney disease.

Gupta R, Plantinga LC, Fink NE, Melamed ML, Coresh J, Fox CS, Levin NW, Powe NR.

JAMA. 2007 Apr 4;297(13):1455-64. Erratum in: JAMA. 2008 Feb 20;299(7):765.

PMID:
17405971
33.

Preferences for current health and their association with outcomes in patients with kidney disease.

Plantinga LC, Fink NE, Bass EB, Boulware LE, Meyer KB, Powe NR.

Med Care. 2007 Mar;45(3):230-7.

PMID:
17304080
34.

Relation between level or change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis.

Plantinga LC, Fink NE, Jaar BG, Huang IC, Wu AW, Meyer KB, Powe NR.

Qual Life Res. 2007 Jun;16(5):755-65. Epub 2007 Feb 8.

PMID:
17286191
35.

Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study.

Plantinga LC, Fink NE, Jaar BG, Sadler JH, Levin NW, Coresh J, Klag MJ, Powe NR.

BMC Health Serv Res. 2007 Jan 9;7:5.

36.

Functional variants in the lymphotoxin-alpha gene predict cardiovascular disease in dialysis patients.

Liu Y, Berthier-Schaad Y, Plantinga L, Fink NE, Tracy RP, Kao WH, Klag MJ, Smith MW, Coresh J.

J Am Soc Nephrol. 2006 Nov;17(11):3158-66. Epub 2006 Sep 20.

37.

Association of clinic vascular access monitoring practices with clinical outcomes in hemodialysis patients.

Plantinga LC, Jaar BG, Astor B, Fink NE, Eustace JA, Klag MJ, Powe NR.

Nephron Clin Pract. 2006;104(4):c151-9. Epub 2006 Aug 10.

PMID:
16902311
38.

Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans.

Chretien JP, Coresh J, Berthier-Schaad Y, Kao WH, Fink NE, Klag MJ, Marcovina SM, Giaculli F, Smith MW.

J Med Genet. 2006 Dec;43(12):917-23. Epub 2006 Jul 13.

39.

Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.

Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR.

Kidney Int. 2006 Jul;70(2):351-7. Epub 2006 May 31.

40.

Speech recognition at 1-year follow-up in the childhood development after cochlear implantation study: Methods and preliminary findings.

Eisenberg LS, Johnson KC, Martinez AS, Cokely CG, Tobey EA, Quittner AL, Fink NE, Wang NY, Niparko JK; CDaCI Investgative Team.

Audiol Neurootol. 2006;11(4):259-68. Epub 2006 May 12.

PMID:
16699259
41.

IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort.

Liu Y, Berthier-Schaad Y, Fallin MD, Fink NE, Tracy RP, Klag MJ, Smith MW, Coresh J.

J Am Soc Nephrol. 2006 Mar;17(3):863-70. Epub 2006 Feb 8. Erratum in: J Am Soc Nephrol. 2006 Nov;17(11):3264.

42.

Serum protein profile and blood cell counts in adult toads Bufo arenarum(Amphibia: Anura: Bufonidae): effects of sublethal lead acetate.

Chiesa ME, Rosenberg CE, Fink NE, Salibián A.

Arch Environ Contam Toxicol. 2006 Apr;50(3):384-91. Epub 2006 Jan 30.

PMID:
16446996
43.

Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients.

Unruh ML, Evans IV, Fink NE, Powe NR, Meyer KB; Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Am J Kidney Dis. 2005 Dec;46(6):1107-16.

PMID:
16310577
44.

Use of dialysis educators beyond nurses and physicians and outcomes in patients with kidney failure.

Plantinga LC, Pham HH, Fink NE, Rubin HR, Jaar BG, Powe NR.

Adv Chronic Kidney Dis. 2005 Oct;12(4):424-32.

PMID:
16198283
45.

Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease.

Jaar BG, Coresh J, Plantinga LC, Fink NE, Klag MJ, Levey AS, Levin NW, Sadler JH, Kliger A, Powe NR.

Ann Intern Med. 2005 Aug 2;143(3):174-83.

PMID:
16061915
46.

Beta-fibrinogen haplotypes and the risk for cardiovascular disease in a dialysis cohort.

Liu Y, Berthier-Schaad Y, Fink NE, Fallin MD, Tracy RP, Klag MJ, Smith MW, Coresh J.

Am J Kidney Dis. 2005 Jul;46(1):78-85.

PMID:
15983960
47.

Preferences, knowledge, communication and patient-physician discussion of living kidney transplantation in African American families.

Boulware LE, Meoni LA, Fink NE, Parekh RS, Kao WH, Klag MJ, Powe NR.

Am J Transplant. 2005 Jun;5(6):1503-12.

48.

Galectin-1 receptors in different cell types.

Elola MT, Chiesa ME, Alberti AF, Mordoh J, Fink NE.

J Biomed Sci. 2005;12(1):13-29. Review.

PMID:
15864736
50.

High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.

Longenecker JC, Klag MJ, Marcovina SM, Liu YM, Jaar BG, Powe NR, Fink NE, Levey AS, Coresh J.

J Am Soc Nephrol. 2005 Jun;16(6):1794-802. Epub 2005 Mar 30.

Supplemental Content

Support Center